Torrent Pharmaceuticals Ltd. (TORP)

Currency in INR
4,924.00
-32.00(-0.65%)
Closed·
TORP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,901.004,987.50
52 wk Range
3,480.605,250.00
Key Statistics
Bid/Ask
4,924.00 / 4,777.50
Prev. Close
4,956
Open
4,956
Day's Range
4,901-4,987.5
52 wk Range
3,480.6-5,250
Volume
394.46K
Average Volume (3m)
646.26K
1-Year Change
36.9033%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TORP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy5,950.00+20.84%5,000.00MaintainAug 03, 2026
ICICI Securities
Hold4,925.00+0.02%4,800.00MaintainJul 31, 2026
Morgan Stanley
Buy5,623.00+14.20%4,580.00UpgradeJul 31, 2026
Kotak
Buy5,000.00+1.54%4,620.00MaintainMay 27, 2026
HSBC
Buy5,050.00+2.56%5,100.00MaintainMay 27, 2026

Torrent Pharmaceuticals Ltd. Earnings Call Summary for Q1/2027

  • Q1 FY2027 revenue surged 55% YoY to INR 4,921 crores; operating EBITDA jumped 61% to INR 1,664 crores with 33.8% margin.
  • JB Pharma merger completed six months early; cost synergies exceed INR 100 crore target, ahead of original INR 90 crore plan.
  • Semaglutide supply disruption to impact sales through August; alternate source secured with full SKU availability expected by month-end.
  • Management withheld full-year combined guidance pending integration progress; expects U.S. profitability in FY2027, Brazil mid-teens growth in Q2.
  • India branded business grew 19% vs. 12% market growth; stock flat at INR 4,872 as investors weigh strong results against cautious outlook.
Last Updated: 2026-07-30, 09:24 a/m
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
15.40 / 15.04
Revenue / Forecast
49.21B / 47.23B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 62.51%
Dividend Yield
0.89%
Industry Median 0.67%
Annualized payout
44.00
Paid unevenly
5-Years Growth
+16.77%
Growth Streak

TORP Income Statement

Compare TORP to Peers and Sector

Metrics to compare
TORP
Peers
Sector
Relationship
P/E Ratio
86.6x35.2x−0.4x
PEG Ratio
15.261.370.00
Price/Book
22.5x6.0x2.6x
Price / LTM Sales
12.0x6.1x3.0x
Upside (Analyst Target)
11.0%5.6%50.7%
Fair Value Upside
Unlock−1.4%7.2%Unlock

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Employees
18258
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
50.52M13.28%252.60B
Other Institutional Investors
246.96M64.93%1.23T
Public Companies & Retail Investors
82.89M21.79%414.46B
Total
380.37M100.00%1.9T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Torrent Investments Private Limited60.78%231,183,4001,155,917,000
Nps Trust2.22%8,442,03342,210,165

People Also Watch

3,457.10
BSEL
+0.64%
1,115.00
SHMF
-2.28%
1,844.30
LAUL
+0.78%
9,218.00
POLC
-1.04%

FAQ

What Is the Torrent Pharma (TORP) Stock Price Today?

The Torrent Pharma stock price today is 4,924.00 INR.

What Stock Exchange Does Torrent Pharma Trade On?

Torrent Pharma is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Torrent Pharma?

The stock symbol for Torrent Pharma is "TORP."

Does Torrent Pharma Pay Dividends? What’s The Current Dividend Yield?

The Torrent Pharma dividend yield is 0.89%.

What Is the Torrent Pharma Market Cap?

As of today, Torrent Pharma market cap is 1.88T INR.

What Is Torrent Pharma's Earnings Per Share (TTM)?

The Torrent Pharma EPS (TTM) is 62.51.

When Is the Next Torrent Pharma Earnings Date?

Torrent Pharma will release its next earnings report on Oct 28, 2026.

From a Technical Analysis Perspective, Is TORP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Torrent Pharma Stock Split?

Torrent Pharma has split 3 times.

How Many Employees Does Torrent Pharma Have?

Torrent Pharma has 18258 employees.

What is the current trading status of Torrent Pharma (TORP)?

As of Aug 07, 2026, Torrent Pharma (TORP) is trading at a price of 4,924.00 INR, with a previous close of 4,956.00 INR. The stock has fluctuated within a day range of 4,901.00 INR to 4,987.50 INR, while its 52-week range spans from 3,480.60 INR to 5,250.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.